# SOCRATES: Steroid or Cyclosporine Removal After Transplantation Using Everolimus

> **NCT00371826** · PHASE4 · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 126 (actual)

## Conditions studied

- Renal Transplanted Recipients

## Interventions

- **DRUG:** Everolimus (RAD001)
- **DRUG:** Cyclosporine (Calcineurin Inhibitor (CNI))
- **DRUG:** Methylprednisone/prednisone
- **DRUG:** Mycophenolate sodium (MPA)

## Key facts

- **NCT ID:** NCT00371826
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-03
- **Primary completion:** 2012-06
- **Final completion:** 2012-06
- **Target enrollment:** 126 (ACTUAL)
- **Last updated:** 2013-08-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00371826

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00371826, "SOCRATES: Steroid or Cyclosporine Removal After Transplantation Using Everolimus". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00371826. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*